AzTrials
AzTrials

AmputationEASENCT02958553

EmPOWERing Active Seniors With Energy

A study testing emPOWER Ankle and Subject's own passive prosthesis in people with Amputation, run by Otto Bock Healthcare Products GmbH at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A pilot study comparing the emPOWER Ankle System to standard carbon fiber prosthetic feet, in active seniors. Read more about this study

Who is it for?
Ages 55 years and older
Conditions the study is for
Amputation
What is being tested?
emPOWER Ankle and Subject's own passive prosthesis
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
8 participants
Where
1 siteUnited States
Study dates
10 Feb 2017to 31 Jul 2018
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 55 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Males and females
  • 55 years or older
  • Subjects with transtibial amputations of either leg at least 1 year prior
  • Suction or elevated vacuum suspension and Socket Comfort Score of at least 6
  • Sock fluctuation of ≤ 8 ply per day
  • K-level rating of 3 or 4 based on the Amputee Mobility Predictor Assessment Tool
Show all 14Show fewer
  • Ability to walk at a walking speed of > 0.75 meters per second
  • Unilateral amputees (up to 7 bilateral amputees can be included, 1 per site in addition to the unilateral amputees who will be analyzed as a separate sub group)
  • Foot size: 25-30 cm
  • Ability to complete a continuous 6-Minute Walk Test
  • Ability to provide written, informed consent
  • Ability to complete study visits and study documents
  • Ability to manage the complexity of a powered device including charging and changing batteries as needed
  • Ability to read and understand English

Who cannot join

  • Subjects who have never used a prosthetic device
  • Less than 55 years of age
  • Weight <150 lbs. or > 287 lbs.
  • Transfemoral amputees
  • Active sores or ulceration on subject's residual limb
  • Sore on contralateral foot.
Show all 16Show fewer
  • Cuff-link socket suspension
  • Socket Comfort Score less than 6
  • Sock fluctuation of > 8 per day
  • K level of 1 or 2
  • Amputation clearance < 8.625"
  • History of stroke or TIA that impairs current walking
  • Recent history of excessive falling defined as more than 2 falls requiring medical assistance in the prior year
  • Medications potentially affecting balance
  • Recent hospitalization (within past 3 months)
  • Cognitive deficiency that would impact ability to charge and change batteries as needed

Trial locations and contacts

1 site in 1 country.

United States1 site
  • UTHealth, Department of Orthopedic Surgery

    Houston, Texas, 77030

Other trials in United States

About this study

A pilot study comparing the emPOWER Ankle System to standard carbon fiber prosthetic feet, in active seniors.

Read the detailed description

The primary objective of this study is to characterize the increase in the distance subjects can walk during a six (6) minute period while wearing the emPOWER Ankle compared to a passive lower-extremity prosthesis.

Conditions
Amputation
Being tested
emPOWER Ankle, Subject's own passive prosthesis
Keywords
Lower Extremity Limb Loss, Prosthesis Use

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • emPOWER AnkleDevice

    The device is 510k cleared and is intended to replace a missing foot and ankle. The emPOWER Ankle is to be used exclusively for fittings of lower-extremity amputations as prescribed by a healthcare professional.

  • Subject's own passive prosthesisDevice

    Devices will vary. Data gathered will form a baseline.

Study groups in NCT02958553
Study groupRoleWhat they receive
emPOWER Ankle (powered prosthesis)OtherThe subject's own passive prosthesis will be used as a baseline and crossed over after the emPOWER has been worn 3-4 months. Then the passive foot will be crossed back to the emPOWER for a final series of tests.
Receives: Device: emPOWER Ankle; Device: Subject's own passive prosthesis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of Participants With Improvement, No Change, or Worsening in Performance in the Six Minute Walk Test (6MWT)

    The proportion of patients with a clinically meaningful change (improvement, no change, worsening) in the walking distance measured by the Six Minute Walk Test (6MWT). 6minWT improvement was defined as a minimum increase of 45 meters.

    Measured: 3 months with the emPOWER ankle

Secondary outcomes (15)
  1. Number of Participants With Improvement, No Change, or Worsening in Performance in the Twelve Minute Walk Test (12MWT)

    The proportion of patients with a clinically meaningful change (improvement, no change, worsening) in the walking distance measured by the Twelve Minute Walk Test (12MWT). 12minWT improvement was defined as a minimum increase of 90 meters.

    Measured: 3 months with the emPOWER ankle

  2. Number of Participants With Improvement, No Change, or Worsening in Performance in the 10 Meter Walk Test (10MWT)

    The proportion of patients with a clinically meaningful change (improvement, no change, worsening) in the walking distance measured by the 10 Meter Walk Test (10MWT). 10MWT improvement was defined as a minimum increase of 0.1 m/s.

    Measured: 3 months with the emPOWER ankle

  3. Number of Participants With Improvement, No Change, or Worsening in Performance in the L-Test

    The proportion of patients with a clinically meaningful change (improvement, no change, worsening) in the walking time measured in the L-Test. L-Test improvement was defined as a minimum decrease of 4.5 seconds.

    Measured: 3 months with the emPOWER ankle

  4. Number of Participants With Improvement, No Change, or Worsening in Performance in the Ramp Test

    The proportion of patients with a clinically meaningful change (improvement, no change, worsening) in the walking time measured in theRamp Test. Ramp Test improvement was defined as a minimum decrease of 6 seconds to complete the test.

    Measured: 3 months with the emPOWER ankle

  5. Number of Participants With Improvement, No Change, or Worsening in Performance in the Activities-specific Balance Confidence (ABC) Scale Score

    The proportion of patients with a clinically meaningful change (improvement, no change, worsening) in abulatory activities measured by the Activities-specific Balance Confidence Scale. Improvement in the ABC was defined as a minimum detectable change of 13% increase in score.

    The ABC Scale is a self-administered questionnaire that asks the patient to rate his or her confidence in performing various ambulatory activities on a scale from 0% (no confidence) to 100% (complete confidence) without losing balance or becoming unsteady. Scores for each of the 16 items will be collected and an average percentage calculated, with scores <67 indicating an increased risk of falling.

    Measured: 3 months with the emPOWER ankle

  6. Number of Participants With Improvement, No Change, or Worsening in Performance in the Falls Efficacy Scale Score

    The Falls Efficacy Scale is a validated 10-item self-report questionnaire designed to assess confidence in the ability to perform 10 activities of daily living without falling as an indicator of how one's fear of falling impacts physical performance. Each item is rated from 1 ("very confident") to 10 ("not confident at all"), and the per item ratings are added to generate a summary total score (10 to 100). Lower scores indicate more confidence and higher scores indicate lack of confidence and greater fear of falling. It has been validated for use in the elderly and persons with amputations. Scores ≥70 indicate an increased fear of falling. Improvement in the Falls Efficiacy Scale was defined as a minimum increase of 2 in the score.

    Measured: 3 months with the emPOWER ankle

  7. Number of Participants With Improvement, No Change, or Worsening in Performance in the Amputee Mobility Predictor (AMP) Assessment

    The AMP is an instrument designed to measure ambulatory potential of lower-limb amputees. Subjects begin the test seated in a hard chair with arms and are tested for a total of 21 items assessing abilities of increasing level of difficulty. Abilities assessed include sitting balance, transfer from chair to chair, standing balance, gait quality, negotiating obstacles, and the use of assistive devices. The total score range for the AMP is 0 to 47 points. A minimal detectable change of 4 points was the definition of improvement.

    Measured: 3 months with the emPOWER ankle

  8. Number of Participants With Improvement, No Change, or Worsening in Performance in the Prosthetic Limb Users Survey of Mobility PLUS-M (12 Item Short Form)

    The PLUS-M is a valid and reliable self-reported measure for the mobility of adults with lower limb amputations. PLUS-M asks about the patient's ability to perform simple and complex tasks. High PLUS-M scores correspond with greater mobility. Improvement in the Mobility PLUS-M (12 item Short Form) was defined by a minimum detectable change of an increase of 5 points in the total score.

    Measured: 3 months with the emPOWER ankle

  9. Number of Participants With Improvement, No Change, or Worsening in Performance in the Patient Specific Functional Scale (PSFS)

    The PSFS is a self-report, goal-attainment measure aimed at identifying functional status limitations that are most relevant to individual patients. The PSFS is a reliable, valid, and efficient measure for detecting clinical change in persons with low back pain and knee dysfunction. Subjects were asked to identify three to five activities that they are having difficulty or are unable to perform because of their injury/condition. For the specified activities, patients were asked to rate their ability to perform each activity at that time (0-10 numerical scale) with '0' being unable to perform the activity, and '10' being able to perform the activity at the same level as they could prior to the injury/condition. The total score was calculated as the sum of the activity scores divided by the number of activities. Changes of >2 in the total score compared to baseline were considered "Improved."

    Measured: 3 months with the emPOWER ankle

  10. Number of Participants With Improvement, No Change, or Worsening in Performance in the Numeric Pain Rating Scale (NPRS)

    The NPRS is a valid and reliable measure of pain that may be used across all musculoskeletal injuries/conditions and complements the PSFS. The patient was asked to rate the pain of their joints, foot, lower back, and if they are using an assistive device any additional affected limbs on average over the last 24 hours on a scale 1-10, with '1' being 'very mild' and '10' being the 'unimaginable unspeakable'. The scores on the NPRS instruments with the emPOWER Ankle were compared to the scores on the subject's passive prosthesis. An improvement was considered a positive change of 1 for at least one area without a corresponding decrease in another.

    Measured: 3 months with the emPOWER ankle

  11. Number of Participants With Improvement, No Change, or Worsening in Performance in Activity (Monitoring Using a Fitbit Over 2-week Periods)

    A Fitbit activity monitor was worn to record the number of steps the Subject took with the prosthesis. The patient returned to the site with the activity monitor and the steps counted were downloaded from the device. In addition, the Subjects were sent home with a prepaid envelope and instructed to mail back the activity monitor if the next visit was more than 3 weeks later, to ensure that the data was not lost. The step counts were downloaded from the device the day the activity monitor was returned to the Investigator. The Investigator recorded the date the patient was affixed with the activity monitor, the date they received the returned activity monitor, and the date they synced the monitor. An improvement was defined as an increase in the average daily step count of 750 steps.

    Measured: 3 months with the emPOWER ankle

  12. Number of Participants With Improvement, No Change, or Worsening in Performance in PROMIS Physical Function

    PROMIS item banks and their short forms are a reliable and precise measurements of patient reported outcome measures. The scores on the PROMIS instruments with the emPOWER Ankle 3 months after fitting will be compared to the scores on the subject's passive prosthesis. PROMIS Physical Function improvement was defined as a minimally clinically important difference (MCID) of an increase of 6.8 in a total score.

    Measured: 3 months with the emPOWER ankle

  13. Number of Participants With Improvement, No Change, or Worsening in Performance in PROMIS Global Health Short Form

    PROMIS item banks and their short forms are a reliable and precise measurements of patient reported outcome measures. The scores on the PROMIS instruments with the emPOWER Ankle 3 months after fitting will be compared to the scores on the subject's passive prosthesis. PROMIS Global Health Short Form improvement was defined as an increase in a total score of 3.5.

    Measured: 3 months with the emPOWER ankle

  14. Number of Participants With Improvement, No Change, or Worsening in Performance in PROMIS Fatigue Short Form (7a)

    PROMIS item banks and their short forms are a reliable and precise measurements of patient reported outcome measures. The scores on the PROMIS instruments with the emPOWER Ankle 3 months after fitting will be compared to the scores on the subject's passive prosthesis. PROMIS Fatigue Short Form (7a) improvement was defined as a minimally clinically important difference (MCID) of an increase of 5 in a total score.

    Measured: 3 months with the emPOWER ankle

  15. Number of Participants With Improvement, No Change, or Worsening in Performance in PROMIS Pain Intensity Short Form (3a)

    PROMIS item banks and their short forms are a reliable and precise measurements of patient reported outcome measures. The scores on the PROMIS instruments with the emPOWER Ankle 3 months after fitting will be compared to the scores on the subject's passive prosthesis. PROMIS Pain Intensity Short Form (3a) improvement was defined as a minimally clinically important difference (MCID) of an increase of 6.9 in a total score.

    Measured: 3 months with the emPOWER ankle

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Nov 2016 (estimated)
  2. Study start10 Feb 2017
  3. Primary completion31 Jul 2018
  4. Study completion31 Jul 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Model description
First the patient data is gathered with the subject's own passive prosthetic. Then switched over to the emPOWER Ankle. Third, the patient's prosthetic is switched back to test for carry-over benefits. Then they are put on the emPOWER for a final series of tests.
Masking
None (open label)
Enrolment
8 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02958553
Sponsor's protocol ID
P16-01
Acronym
EASE
Status last verified
Apr 2020
First submitted
2 Nov 2016
Last updated
24 Apr 2020
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing emPOWER Ankle and Subject's own passive prosthesis in people with Amputation, run by Otto Bock Healthcare Products GmbH at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 14 inclusion and 16 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Apr 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 9 Apr 2020). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of Participants With Improvement, No Change, or Worsening in Performance in the Six Minute Walk Test (6MWT) (time frame: 3 months with the emPOWER ankle). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Apr 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in